PharmGen Science, Inc. (004720.KS)
KRW 4370.0
(-1.47%)
KRW 4370.0
(-1.47%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 351.99 KRW | -92.17% |
| 2022 | 4498.10 KRW | 103.9% |
| 2021 | 2206.02 KRW | 226.83% |
| 2020 | 674.98 KRW | 3200.64% |
| 2019 | 20.45 KRW | -94.76% |
| 2018 | 390.15 KRW | -1.23% |
| 2017 | 395.00 KRW | 8.52% |
| 2016 | 364.00 KRW | 56.22% |
| 2015 | 233.00 KRW | 140.24% |
| 2014 | -579.00 KRW | -23.47% |
| 2013 | -468.94 KRW | 36.63% |
| 2012 | -740.00 KRW | 47.06% |
| 2011 | -1397.73 KRW | -209.0% |
| 2010 | -452.34 KRW | -26.27% |
| 2009 | -358.22 KRW | 82.78% |
| 2008 | -2079.71 KRW | -5166.42% |
| 2007 | -39.49 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 57.91 KRW | -46.0% |
| 2024 Q1 | 107.41 KRW | 700.73% |
| 2023 Q4 | -17.88 KRW | 86.55% |
| 2023 Q1 | 92.83 KRW | 214.73% |
| 2023 Q2 | 424.18 KRW | 356.94% |
| 2023 Q3 | -132.96 KRW | -131.35% |
| 2023 FY | - KRW | -92.17% |
| 2022 Q4 | -80.91 KRW | -605.69% |
| 2022 Q3 | 16.00 KRW | -97.15% |
| 2022 Q2 | 561.00 KRW | -80.25% |
| 2022 Q1 | 2840.00 KRW | 214.82% |
| 2022 FY | - KRW | 103.9% |
| 2021 Q3 | 256.00 KRW | 154.24% |
| 2021 Q2 | -472.00 KRW | -130.97% |
| 2021 Q1 | 1524.00 KRW | 225.58% |
| 2021 FY | - KRW | 226.83% |
| 2021 Q4 | 902.11 KRW | 252.39% |
| 2020 Q2 | 117.00 KRW | 224.47% |
| 2020 FY | - KRW | 3200.64% |
| 2020 Q4 | 468.09 KRW | 153.02% |
| 2020 Q3 | 185.00 KRW | 58.12% |
| 2020 Q1 | -94.00 KRW | -49.37% |
| 2019 Q4 | -62.93 KRW | -384.08% |
| 2019 Q2 | 57.00 KRW | 26.67% |
| 2019 FY | - KRW | -94.76% |
| 2019 Q1 | 45.00 KRW | -59.83% |
| 2019 Q3 | -13.00 KRW | -122.81% |
| 2018 Q4 | 112.01 KRW | 433.38% |
| 2018 FY | - KRW | -1.23% |
| 2018 Q2 | 176.00 KRW | 117.28% |
| 2018 Q3 | 21.00 KRW | -88.07% |
| 2018 Q1 | 81.00 KRW | 11.74% |
| 2017 Q2 | 112.00 KRW | 55.56% |
| 2017 FY | - KRW | 8.52% |
| 2017 Q4 | 72.49 KRW | -46.3% |
| 2017 Q3 | 135.00 KRW | 20.54% |
| 2017 Q1 | 72.00 KRW | -50.54% |
| 2016 Q1 | 163.00 KRW | 108566.67% |
| 2016 Q3 | 49.00 KRW | 390.0% |
| 2016 Q4 | 145.57 KRW | 197.08% |
| 2016 Q2 | 10.00 KRW | -93.87% |
| 2016 FY | - KRW | 56.22% |
| 2015 Q4 | 0.15 KRW | 100.11% |
| 2015 FY | - KRW | 140.24% |
| 2015 Q3 | -134.00 KRW | -159.29% |
| 2015 Q2 | 226.00 KRW | 30.64% |
| 2015 Q1 | 173.00 KRW | 154.19% |
| 2014 Q3 | -130.00 KRW | -116.67% |
| 2014 Q2 | -60.00 KRW | 91.78% |
| 2014 FY | - KRW | -23.47% |
| 2014 Q1 | -730.00 KRW | -154.57% |
| 2014 Q4 | -319.27 KRW | -145.59% |
| 2013 Q3 | -120.00 KRW | -1300.0% |
| 2013 Q4 | -286.76 KRW | -138.97% |
| 2013 FY | - KRW | 36.63% |
| 2013 Q1 | -62.21 KRW | 90.78% |
| 2013 Q2 | 10.00 KRW | 116.07% |
| 2012 Q4 | -674.66 KRW | -1249.32% |
| 2012 FY | - KRW | 47.06% |
| 2012 Q2 | -94.24 KRW | -171.43% |
| 2012 Q3 | -50.00 KRW | 46.94% |
| 2012 Q1 | 131.93 KRW | 126.66% |
| 2011 Q1 | 160.20 KRW | 124.67% |
| 2011 Q4 | -494.89 KRW | -537.65% |
| 2011 FY | - KRW | -209.0% |
| 2011 Q2 | -1196.47 KRW | -846.86% |
| 2011 Q3 | 113.08 KRW | 109.45% |
| 2010 Q3 | 47.12 KRW | -50.0% |
| 2010 Q2 | 94.24 KRW | 399.95% |
| 2010 Q1 | 18.85 KRW | 144.02% |
| 2010 FY | - KRW | -26.27% |
| 2010 Q4 | -649.39 KRW | -1478.16% |
| 2009 Q2 | -357.45 KRW | -108.89% |
| 2009 Q4 | -42.82 KRW | -126.35% |
| 2009 Q3 | 162.48 KRW | 145.46% |
| 2009 Q1 | -171.12 KRW | 92.45% |
| 2009 FY | - KRW | 82.78% |
| 2008 Q1 | 315.91 KRW | 348.03% |
| 2008 Q3 | 105.30 KRW | 166.67% |
| 2008 Q4 | -2265.24 KRW | -2251.23% |
| 2008 FY | - KRW | -5166.42% |
| 2008 Q2 | -157.95 KRW | -150.0% |
| 2007 Q4 | -127.37 KRW | 41.41% |
| 2007 Q2 | 39.49 KRW | -85.24% |
| 2007 FY | - KRW | 0.0% |
| 2007 Q3 | -217.38 KRW | -650.47% |
| 2007 Q1 | 267.52 KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Daewoong Co., Ltd. | 3691.68 KRW | 90.465% |
| Wooridul Huebrain Limited | -138.00 KRW | 355.065% |